NCT06761469

Brief Summary

The goal of this clinical trial is to assess whether a multifactorial active case-finding strategy improves the detection of leprosy cases in Brazil compared to usual screening practices. The main questions it aims to answer are: \- Does the intervention increase the number of new leprosy cases detected compared to standard care? Participants will:

  • Receive community awareness about leprosy.
  • Be screened using the Leprosy Suspicion Questionnaire at priority areas identified by georeference tools.
  • Undergo clinical evaluation by a trained medical team.
  • If leprosy is diagnosed, affected patients will collect complementary laboratory exams Healthcare professionals from primary care units will receive training in leprosy, while researchers will monitor changes in leprosy incidence over a 12-month period using data from Brazil's national notification system. The study will provide insights into underdiagnosis and the clinical profiles of patients who have been diagnosed.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,925

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Jun 2025May 2026

First Submitted

Initial submission to the registry

December 30, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 7, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

12 months

First QC Date

December 30, 2024

Last Update Submit

April 26, 2026

Conditions

Keywords

LeprosyActive-case findingCluster stepped-wedgeClinical trialBrazil

Outcome Measures

Primary Outcomes (1)

  • New cases of leprosy

    Number of new cases of leprosy: incidence rate of leprosy per 100,000 inhabitants.

    From the date of identification of at least one positive response in the Leprosy Suspicion Questionnaire until the date of confirmation or ruling out leprosy, assessed up to 2 months.

Secondary Outcomes (1)

  • Leprosy Suspicion Questionnaire usefulness

    From the application date of the Leprosy Suspicion Questionnaire and the rapid test until the date of confirmation or ruling out leprosy, it is assessed for up to 2 months.

Study Arms (2)

Multifaceted intervention

EXPERIMENTAL

Implementation of active-case finding strategies

Other: Implementing active-case finding strategies

Standard of care

NO INTERVENTION

Routine screening

Interventions

Implementation of a multifactorial active-case finding strategy, including: (1) raising awareness among the population about leprosy; (2) theoretical and practical educational training for healthcare workers; (3) georeferencing of historical and existing cases in the municipality (from 2012 to 2023) and of new cases diagnosed throughout the study (dynamic changes); (4) screening tools for signs/symptoms of the disease (application of Leprosy Suspicion Questionnaire); and (5) serological profile (rapid test) of patients with reported signs/symptoms (positive answers Leprosy Suspicion Questionnaire).

Multifaceted intervention

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • (I) Municipalities
  • Municipality recognized by the Brazilian Institute of Geography and Statistics as part of the Brazilian Federation.
  • Municipality with operational epidemiological classification by the Ministry of Health (BMoH) as: 'municipalities with cases in the period from 2015 to 2019'.
  • Municipality with authorization/consent from the government to participate in the study.
  • (II) Primary Health Units (Unidade Básica de Saúde or UBS) • UBS with territorial coverage (linked population) within the participating municipality.
  • (III) Participants
  • Patients with positive Leprosy Suspicion Questionnaire (LSQ): children under five years old with Free and Informed Consent Form (ICF) signed by parents/guardians, 5-17 years old with ICF signed by parents/guardians and Free and Informed Assent Form (IAF) signed by the minor, and patients over 18 years old with ICF signed for: rapid test collection, comorbidity questionnaire and clinical evaluation; and if leprosy diagnosis is confirmed, collection of complementary exams.

You may not qualify if:

  • (I) Municipalities
  • Municipality with extreme population size (municipalities with a number of inhabitants lower than the 10th percentile and higher than the 90th percentile).
  • Municipality with operational epidemiological classification by the BMoH as: 'municipalities without cases in the period 2015 to 2019'.
  • Municipalities with active or recent participation (less than one year) in other active-finding strategies, in addition to the usual ones: ministerial, Non-Governmental Organizations (NGOs), academic, among others.
  • (II) Primary Health Units
  • UBS with limited multidisciplinary team (absence of physicians, nurse and/or community health agents).
  • UBS with difficult access (no access by land, i.e. riverside populations).
  • UBS with territorial coverage exclusively of indigenous populations.
  • (III) Participants
  • LSQ negative.
  • Patients with a previous diagnosis or history of treated leprosy.
  • Patients residing/registered outside the selected municipality.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Alemão Oswaldo Cruz

São Paulo, 01327-001, Brazil

RECRUITING

MeSH Terms

Conditions

Leprosy

Condition Hierarchy (Ancestors)

Mycobacterium Infections, NontuberculousMycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfections

Study Officials

  • Rosa C Lucchetta, PhD

    Hospital Alemão Oswaldo Cruz

    STUDY DIRECTOR

Central Study Contacts

Sebastian A Vernal, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
Data analyst (statistician)
Purpose
SCREENING
Intervention Model
SEQUENTIAL
Model Details: Cluster stepped-wedge
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

December 30, 2024

First Posted

January 7, 2025

Study Start

June 1, 2025

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

May 31, 2026

Last Updated

April 28, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, CSR

Locations